Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Current Assets (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Current Assets readings, the most recent being $62.2 million for Q4 2021.

  • On a quarterly basis, Current Assets rose 126.68% to $62.2 million in Q4 2021 year-over-year; TTM through Dec 2021 was $62.2 million, a 126.68% increase, with the full-year FY2021 number at $62.2 million, up 126.68% from a year prior.
  • Current Assets hit $62.2 million in Q4 2021 for Minerva Neurosciences, down from $67.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $81.7 million in Q1 2021 to a low of $27.4 million in Q4 2020.
  • Median Current Assets over the past 3 years was $47.1 million (2019), compared with a mean of $52.3 million.
  • Biggest five-year swings in Current Assets: tumbled 41.79% in 2020 and later skyrocketed 126.68% in 2021.
  • Minerva Neurosciences' Current Assets stood at $47.1 million in 2019, then plummeted by 41.79% to $27.4 million in 2020, then skyrocketed by 126.68% to $62.2 million in 2021.
  • The last three reported values for Current Assets were $62.2 million (Q4 2021), $67.4 million (Q3 2021), and $75.2 million (Q2 2021) per Business Quant data.